Aspirin could help boost therapies to treat cancer
The latest therapies that fight cancer could work better
when combined with aspirin, research has suggested. Scientists from the Francis
Crick Institute in London say the anti-inflammatory pain killer suppresses a
cancer molecule that allows tumours to evade the body’s immune defences.
Laboratory tests
have shown that skin, breast and bowel cancer cells often generate large
amounts of this molecule, called prostaglandin E2 (PGE2).
But Aspirin is one
of a family of drugs that sends messages to the brain to block production of
PGE2 and this means cancer cells can be attacked by the body’s natural defences.
No comments:
Post a Comment